JPH0370720B2 - - Google Patents
Info
- Publication number
- JPH0370720B2 JPH0370720B2 JP2740784A JP2740784A JPH0370720B2 JP H0370720 B2 JPH0370720 B2 JP H0370720B2 JP 2740784 A JP2740784 A JP 2740784A JP 2740784 A JP2740784 A JP 2740784A JP H0370720 B2 JPH0370720 B2 JP H0370720B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- formula
- group
- steroid
- estrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 claims description 10
- -1 propylene dioxy group Chemical group 0.000 claims description 8
- 241000228143 Penicillium Species 0.000 claims description 7
- BJALMYZFOSDDSF-LJRKRDDSSA-N (8r,9r,10s,13s,14s)-13-methyl-1,2,4,5,6,7,8,9,10,11,12,14-dodecahydrocyclopenta[a]phenanthrene-3,17-dione Chemical class C1C(=O)CC[C@@H]2[C@H]3CC[C@](C)(C(C=C4)=O)[C@@H]4[C@@H]3CCC21 BJALMYZFOSDDSF-LJRKRDDSSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004043 oxo group Chemical group O=* 0.000 claims description 2
- 125000005905 mesyloxy group Chemical group 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 238000005907 ketalization reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000228150 Penicillium chrysogenum Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- NANJFPZFEUIDND-MYBOQGECSA-N (8r,9s,10r,13s,14s,15s)-13-ethyl-15-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)(C(C[C@@H]4O)=O)[C@@H]4[C@@H]3CCC2=C1 NANJFPZFEUIDND-MYBOQGECSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- KVUXYQHEESDGIJ-UHFFFAOYSA-N 10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,16-diol Chemical compound C1CC2CC(O)CCC2(C)C2C1C1CC(O)CC1(C)CC2 KVUXYQHEESDGIJ-UHFFFAOYSA-N 0.000 description 1
- QPYKYDBKQYZEKG-UHFFFAOYSA-N 2,2-dimethylpropane-1,1-diol Chemical compound CC(C)(C)C(O)O QPYKYDBKQYZEKG-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 241000228145 Penicillium brevicompactum Species 0.000 description 1
- 241000228172 Penicillium canescens Species 0.000 description 1
- 241000519895 Penicillium janczewskii Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、一般式():
〔式中Xは、オキソ基又はプロピレンジオキシ
基を表わし、△は1個の二重結合及び2個の単
結合により隣接炭素原子と結合している炭素原
子を表わし、R1はメチル基を表わす〕のエス
トレン−3,17−ジオン誘導体を製造に関し、
これは、一般式():
〔式中R1は前記と同じものを表わす〕のステ
ロイドをペニシリウム属の菌培養物を用いて醗
酵させ、生じた一般式():
〔式中R1は前記のものを表わす〕の15α−ヒド
ロキシステロイドを任意の順序で、2〜6個の
炭素原子を有するアルカンジオール又はo−ジ
フエノールを用いて酸性触媒の存在下にケター
ル化し、かつ、塩基の存在でスルホン酸クロリ
ドを用いてアシル化し、かつ得られた一般式
():
〔式中△及びR1は前記と同じものを表わし、
X′は炭素原子2〜6個を有するアルキレンジ
オキシ基又はo−フエニレンジオキシ基を表わ
し、Yはアルキルスルホニル基又はアリールス
ルホニル基を表わす〕の化合物を塩基で処理す
ることにより一般式()の△15−ステロイド
に変じ、所望の場合には、得られたケタールを
公知方法で加水分解することよりなる。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to the general formula (): [In the formula, X represents an oxo group or a propylene dioxy group, △ represents a carbon atom bonded to an adjacent carbon atom through one double bond and two single bonds, and R 1 represents a methyl group. Regarding the production of an estrene-3,17-dione derivative of
This is the general formula (): [In the formula, R 1 represents the same thing as above] is fermented using a Penicillium genus bacterial culture, resulting in a general formula (): ketalizing the 15α-hydroxysteroid of the formula in which R 1 is as defined above with an alkanediol or o-diphenol having 2 to 6 carbon atoms in any order in the presence of an acidic catalyst; and acylated with sulfonic acid chloride in the presence of a base, and the obtained general formula (): [In the formula, △ and R 1 represent the same as above,
X' represents an alkylenedioxy group or o-phenylenedioxy group having 2 to 6 carbon atoms, and Y represents an alkylsulfonyl group or an arylsulfonyl group] by treating with a base a compound of the general formula ( ) to the Δ15 -steroid and, if desired, by hydrolyzing the obtained ketal by known methods.
一般式()のエストレン−3,17−ジオン
誘導体は、公知の薬物学的作用を有する物質で
あり、かつ/又は、薬物学的に有効なステロイ
ドを製造するための重要な中間体であり、これ
は、従来公知の方法では非常に経費のかかる多
工程合成法を用いてのみ製造できたものである
〔西ドイツ特許出願公開公報第1593500号、同
1593501号及び同第1643050号及びJ.フリード
(Fried)及びJ.A.エドワード(Edwards)のオ
ルガニツク・リアクシヨン・イン・ステロイ
ド・ケミストリイズ(Or−ganic Reaction in
Steroid Chemistrys;Van Nostrand
Reinhold Comp.New York発行)(1972年)
第1巻301頁以後参照〕。 Estrene-3,17-dione derivatives of the general formula () are substances with known pharmacological effects and/or are important intermediates for producing pharmaceutically effective steroids, This could only be produced by the conventionally known method using a very expensive multi-step synthesis method [West German Patent Application No. 1593500, ibid.
1593501 and 1643050 and J. Fried and J.A. Edwards, Organic Reaction in Steroid Chemistry
Steroid Chemistry; Van Nostrand
Reinhold Comp.New York) (1972)
See Volume 1, pages 301 et seq.].
これに反して、本発明方法は、一般式のエ
ストレン−3,17−ジオン誘導体を公知方法を
用いて可能なよりも簡単な方法でかつ高収率で
製造できる利点を有する。 On the contrary, the process of the invention has the advantage that estrene-3,17-dione derivatives of the general formula can be prepared in a simpler manner and with higher yields than is possible using known processes.
本発明方法の第1工程では、一般式のステ
ロイドをペニシリウム属の菌培養物と共に醗酵
させる。この醗酵のためには、例えば次の菌株
が好適である;
ペニシリウム・カネセンス(Penicillium
canescens)(ATCC 10419)、ペニシリウム・
クリソゲヌム(Penicillium chrysogenum)
(ATCC 10003)、ペニシリウム・ニグリカンス
(Penicillium nigricans)(ATCC 9439)、ペ
ニシリウム・ストロニフエルム(Penicillium
stoloniferum)(ATCC 14586)又は殊にペニ
シリウム・ライストリツキイ(Penicillium
raistrickii)(ATCC 10490)。この菌株を用い
る醗酵は、通例、菌培養物を用いるステロイド
の微生物学的ヒドロキシル化の際に使用される
条件下に実施される。 In the first step of the process of the invention, the steroid of the general formula is fermented with a Penicillium fungus culture. For this fermentation, the following strains are suitable, for example: Penicillium canescens
canescens) (ATCC 10419), Penicillium
Chrysogenum (Penicillium chrysogenum)
(ATCC 10003), Penicillium nigricans (ATCC 9439), Penicillium stronifelum (Penicillium
stoloniferum (ATCC 14586) or especially Penicillium raistritskii
raistrickii) (ATCC 10490). Fermentations using this strain are carried out under conditions customarily used during microbiological hydroxylation of steroids using fungal cultures.
前記条件下に、一般式のステロイドは、意
外に高い収率でヒドロキシル化されて一般式
の15α−ヒドロキシステロイドにすることがで
きる。 Under the above conditions, steroids of the general formula can be hydroxylated to 15α-hydroxysteroids of the general formula in surprisingly high yields.
この好適な結果は、予測できなかつた。それ
というのも、公知のペニシリウム属菌は、ステ
ロイドを15α−位でヒドロキシル化する能力を
有するだけでなく、ステロイドを6β位又は11α
−位でヒドロキシル化し、ケトステロイドを還
元して相応するヒドロキシステロイドにするこ
ともできるからである。 This favorable result was unexpected. This is because known Penicillium bacteria not only have the ability to hydroxylate steroids at the 15α-position, but also have the ability to hydroxylate steroids at the 6β-position or the 11α-position.
This is because it is also possible to hydroxylate at the - position and reduce the ketosteroid to the corresponding hydroxysteroid.
本発明方法の第2及び第3工程で、一般式
()の15α−ヒドロキシステロイドは、任意
の順序でアルカンジオール又はo−ジフエノー
ルを用いてケタール化され、かつスルホン酸ク
ロリドを用いてアシル化される。 In the second and third steps of the process of the invention, the 15α-hydroxysteroids of general formula () are ketalized with alkanediols or o-diphenols in any order and acylated with sulfonic acid chlorides. Ru.
選択的ケタール化は、通例3−ケト−△4−
ステロイドのケタール化に使用される条件下で
実施される。例えばステロイドとアルカンジオ
ール(例えばグリコール、1,3−プロパンジ
オール、2,3−ブタンジオール又は2,2−
ジメチルプロパンジオール)又はo−ジフエニ
ロールとを不溶性溶剤(例えばベンゾール、ク
ロロホルム、塩化メチレン、テトラクロルエタ
ン、ジエチルエーテル又はテトラヒドロフラ
ン)中で、触媒(例えば塩化水素、硫酸、過塩
素酸、トリフルオル酢酸、p−トルオールスル
ホン酸)を用いて反応させることができる。ケ
タール化生成物の高収率を得るために、反応混
合物に有利に水結合剤(例えば硫酸カルシウ
ム、硫酸マグネシウム、分子篩又はギ酸トリア
ルキルエステル)を加える。 Selective ketalization typically involves 3-keto-△ 4 −
It is carried out under conditions used for ketalization of steroids. For example, steroids and alkanediols (e.g. glycols, 1,3-propanediol, 2,3-butanediol or 2,2-
dimethylpropanediol) or o-diphenyrol in an insoluble solvent (e.g. benzole, chloroform, methylene chloride, tetrachloroethane, diethyl ether or tetrahydrofuran) with a catalyst (e.g. hydrogen chloride, sulfuric acid, perchloric acid, trifluoroacetic acid, p- Toluolsulfonic acid) can be used for the reaction. In order to obtain high yields of ketalized products, water binders such as calcium sulfate, magnesium sulfate, molecular sieves or formic acid trialkyl esters are preferably added to the reaction mixture.
このケタール化の際に、17−ケト基も激しい
反応条件下に、かつ長い反応時間で、共にケタ
ール化することが原則的に可能である。これを
さけるために、最適反応時間を常法で予備実験
で測定することが有利である。 During this ketalization, it is in principle possible to also ketalize the 17-keto group under aggressive reaction conditions and over long reaction times. In order to avoid this, it is advantageous to determine the optimum reaction time in the usual manner in preliminary experiments.
このケタール化反応の際に、ステロイド中に
存在する△4−二重結合は、△5(6)−位又は△
5(10)−位に移行される。この二重結合移行は、
本発明方法の実施にとつて重要ではない。それ
というのは、引続くケタール分解(これは、薬
物学的に有効なステロイドの製造のためには常
に必要である)の際に再び3−ケト−△4−構
造を有するステロイドが得られるからである。 During this ketalization reaction, the △ 4 -double bond present in the steroid is transferred to the △ 5(6) -position or △
5(10) Moved to − position. This double bond transition is
It is not critical to the implementation of the method of the invention. This is because during the subsequent ketal decomposition, which is always necessary for the production of pharmaceutically effective steroids, steroids with the 3-keto-△ 4 -structure are again obtained. It is.
アルキルスルホン酸クロリドを用いる15α−
ヒドロキシ基のアシル化は、このために公知の
操作法で実施される。例えば15α−ヒドロキシ
ステロイドを例えばスルホン酸クロリド(例え
ばベンゾールスルホン酸クロリド、p−トルオ
ールスルホン酸クロリド又は殊にメタンスルホ
ン酸クロリド)と、3級アミン(例えばピリジ
ン、ルチジン、コリジン又は4−ジメチルアミ
ノピリジン)の存在で反応させることができ
る。 15α- using alkylsulfonic acid chloride
Acylation of the hydroxy group is carried out using known procedures for this purpose. For example, a 15α-hydroxysteroid can be combined with a sulfonic acid chloride (e.g. benzenesulfonic acid chloride, p-toluolsulfonic acid chloride or especially methanesulfonic acid chloride) and a tertiary amine (e.g. pyridine, lutidine, collidine or 4-dimethylaminopyridine). ) can cause a reaction.
こうして得られた一般式()の化合物は、
塩基での処理により一般式()の△15−ステ
ロイドに変えることができる。 The compound of general formula () obtained in this way is
It can be converted into the Δ15 -steroid of the general formula () by treatment with a base.
スルホン酸基の除去は、塩基の存在で実施さ
れる。好適な塩基は例えばアルカリ金属水酸化
物、アルカリ土類金属水酸化物、アルカリ金属
炭酸塩、低級カルボン酸のアルカリ金属塩又は
3級アミンである。 Removal of the sulfonic acid group is carried out in the presence of a base. Suitable bases are, for example, alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal carbonates, alkali metal salts of lower carboxylic acids or tertiary amines.
好適な塩基の例としては次のものが挙げられ
る:水酸化ナトリウム、水酸化カリウム、水酸
化カルシウム、炭酸ナトリウム、炭酸カリウ
ム、酢酸ナトリウム、酢酸カリウム、ピリジ
ン、ルチジン又はコリジン。この反応のために
3級アミンを使用する際に、これらは、同時に
溶剤としても役立ち、無機塩基使用の際には、
反応は、有利に双極性で中性の溶剤例えばジメ
チルホルムアミド、N−メチルアセタミド、N
−メチルピロリドン、アセトニトリル、ジメチ
ルスルホキシド又はヘキサメチル燐酸トリアミ
ドの存在で、実施される。 Examples of suitable bases include: sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, pyridine, lutidine or collidine. When using tertiary amines for this reaction, they simultaneously serve as solvents, and when using inorganic bases,
The reaction is preferably carried out in dipolar and neutral solvents such as dimethylformamide, N-methylacetamide, N
- carried out in the presence of methylpyrrolidone, acetonitrile, dimethylsulfoxide or hexamethylphosphoric triamide.
これらの除去の際には、類似の除去で公知
(J.Amer.Chem.Soc.78 1956年、6347頁参照)
のように、1次的に形成された△15−二重結合
が異性化されて△14−二重結合になる危険があ
る。これをさけるためには、最適温度及び反応
時間(これらは予備実験で測定できる)を正確
に保持することに注意すべきである。この除去
を、低級カルボン酸のアルカリ金属塩(特に酢
酸ナトリウム又は酢酸カリウム)の使用下に双
極性で中性の溶剤中、−20℃〜+40℃の反応温
度で実施する際には、異性化の危険は存在しな
い。これらの条件下でスルホン酸基は意外に
も、塩基のカルボン酸残基に対して交換され
ず、△15−二重結合の形成下に除かれる。 For these removals, similar removals are known (see J.Amer.Chem.Soc.78 1956, p. 6347).
As in, there is a risk that the primarily formed △ 15 - double bond is isomerized and becomes a △ 14 - double bond. To avoid this, care should be taken to maintain exactly the optimum temperature and reaction time (these can be determined in preliminary experiments). When this removal is carried out using alkali metal salts of lower carboxylic acids (in particular sodium or potassium acetate) in dipolar neutral solvents at reaction temperatures between -20 °C and +40 °C, the isomerization There is no danger of Under these conditions, the sulfonic acid group is surprisingly not exchanged for the carboxylic acid residue of the base, but is removed under the formation of a Δ 15 -double bond.
所望の場合には、得られたケタールを公知方
法で酸水溶液での処理により加水分解すること
ができる。他方、ケタールそのものは、後の使
用例中で17β−ヒドロキシ−18−メチル−17α
−エチニル−15β,16β−メチレン−4−エス
トレン−3−オンの合成の例で、詳説されるよ
うに、薬物学的に有効なステロイドを製造する
ための中間体としても使用できる。 If desired, the ketals obtained can be hydrolyzed in known manner by treatment with aqueous acids. On the other hand, the ketal itself is 17β-hydroxy-18-methyl-17α in later usage examples.
As detailed in the example of the synthesis of -ethynyl-15β,16β-methylene-4-estren-3-one, it can also be used as an intermediate for the production of pharmaceutically effective steroids.
次に実施例につき本発明を説明する。 The invention will now be explained with reference to examples.
例 1
(a) 120℃で30分間オートクレーブ中で減菌し
た、グルコース3.0%、コーンステイープ1.0
%、NaNO30.2%、KH2PO40.1%、
K2HPO40.2%、MgSO40.05%、FeSO40.002%
及びKCl0.05%を含有する栄養液500mlを有す
る2l−エーレンマイヤーフラスコにペニシリウ
ム・ライストリツキイ(ATCC 10490)の凍結
乾燥培養物を接種し、30℃で72時間回転撹拌機
上で振動する。次いでこの予備培養物250mlを、
120℃及び1.1atu¨で滅菌した同じ組成の媒体15
の充填されている20l−ガラス製醗酵槽に接
種する。抑泡剤としてのシリコンSHの添加の
もとに、29℃で空気(10/min)を吹き込み
ながら、0.7atu¨圧及び撹拌(220回転/min)
下に24時間醗酵させる。Example 1 (a) Glucose 3.0%, corn staple 1.0, sterilized in an autoclave at 120°C for 30 minutes.
%, NaNO3 0.2%, KH2PO4 0.1 %,
K2HPO4 0.2 %, MgSO4 0.05%, FeSO4 0.002%
A 2 l Erlenmeyer flask with 500 ml of nutrient solution containing 0.05% KCl is inoculated with a freeze-dried culture of Penicillium leistritskii (ATCC 10490) and shaken on a rotary stirrer for 72 hours at 30°C. Then 250 ml of this preculture was added to
Media of the same composition sterilized at 120°C and 1.1 atu¨15
Inoculate a 20 l glass fermenter filled with With the addition of silicone SH as a foam suppressant, at 29°C and with air (10/min) blowing, 0.7 atu¨pressure and stirring (220 revolutions/min).
Ferment for 24 hours.
培養液1.8を無菌条件下に培養媒体と同じ
組成の前記と同様に滅菌した栄養媒体26中に
移し、予備醗酵培養と同じ条件下で醗酵させ
る。12時間後に、ツイーン(Tween)80水溶
液の存在で蒸溜水中のnat.−18−メチル−4−
エストレン−3,17−ジオン(ここでnat.は、
このステロイドが天然のステロイド配位を有す
ることを意味する)120gの滅菌細分懸濁液2
を加え更に醗酵させる。 The culture solution 1.8 is transferred under aseptic conditions into a similarly sterilized nutrient medium 26 of the same composition as the culture medium and fermented under the same conditions as the prefermentation culture. After 12 hours, nat.-18-methyl-4-
Estrene-3,17-dione (where nat.
120 g of sterile subdivided suspension (meaning this steroid has natural steroid coordination) 2
Add and further ferment.
変換の経過は醗酵試料のメチルイソブチルケ
トン−抽出物の薄層クロマトグラフイ分析によ
り追跡する。約70時間の接触時間の後に、変換
は完全である。次いでミセルを濾取し、培養液
をメチルイソブチルケトン各20で2回抽出す
る。これと平行して濾取したミセルをメチルイ
ソブチルケトン、アセトン及び水からなる混合
物と激しく撹拌して、ステロイド物質がもはや
検出できなくなるまで抽出する。 The progress of the conversion is followed by thin layer chromatographic analysis of the methyl isobutyl ketone extract of the fermentation sample. After about 70 hours of contact time, the conversion is complete. The micelles are then filtered off and the culture solution is extracted twice with 200 ml of methyl isobutyl ketone. In parallel, the micelles filtered off are vigorously stirred with a mixture of methyl isobutyl ketone, acetone and water and extracted until the steroid substances can no longer be detected.
有機抽出溶液を一緒にし、真空中50℃の浴温
で蒸発乾涸させる。褐色結晶性残分をシリコン
油の除去のためにヘキサンで数回洗浄し、乾燥
させ、最後に、活性炭で処理の後に酢酸エステ
ルから再結晶させると、融点175〜177℃の純粋
なnat.−15α−ヒドロキシ−18−メチル−4−
エストレン−3,17−ジオン97.3g(理論量の
76.5%)が得られる。 The organic extract solutions are combined and evaporated to dryness in vacuo at a bath temperature of 50°C. The brown crystalline residue is washed several times with hexane to remove the silicone oil, dried and finally, after treatment with activated carbon, recrystallized from acetic acid ester to give pure nat.- with a melting point of 175-177 °C. 15α-hydroxy-18-methyl-4-
97.3 g of estrene-3,17-dione (theoretical amount)
76.5%).
(b) nat.15α−ヒドロキシ−18−メチル−4−エ
ストレン−3,17−ジオン32gに塩化メチレン
240ml及びo−ギ酸エチルエステル64ml中で、
2,2−ジメチル−1,3−プロパンジオール
96g及びp−トルオールスルホン酸320mgを加
え、30分間、窒素気下に50℃で撹拌する。次い
で、エーテルで稀釈し、炭酸水素ナトリウム溶
液及び水で洗浄し、乾燥させ、蒸発乾涸させ
る。残分をシリカゲルのクロマトグラフイにか
けると、nat.15α−ヒドロキシ−3,3−(2′,
2′−ジメチル−1′,3′−プロピレンジオキシ)−
18−メチル−5−もしくは−5(10)−エストレン
−17−オン37gが油状物として得られる。(b) Methylene chloride in 32 g of nat.15α-hydroxy-18-methyl-4-estrene-3,17-dione
In 240 ml and 64 ml of o-formic acid ethyl ester,
2,2-dimethyl-1,3-propanediol
Add 96 g and 320 mg of p-toluolsulfonic acid and stir for 30 minutes at 50° C. under nitrogen atmosphere. It is then diluted with ether, washed with sodium bicarbonate solution and water, dried and evaporated to dryness. The residue was chromatographed on silica gel and the nat.15α-hydroxy-3,3-(2′,
2'-dimethyl-1',3'-propylenedioxy)-
37 g of 18-methyl-5- or -5(10)-estren-17-one are obtained as an oil.
(c) nat.15α−ヒドロキシ−3,3−(2′,2′−ジ
メチル−1′,3′−プロピレンジオキシ)−18−
メチル−5−もしくは−5(10)−エストレン−17
−オン37gにピリジン370ml中、氷冷下にメチ
レンスルホクロリド27.1mlを加え、氷浴温度で
3時間撹拌する。次いで氷水中に撹拌導入し、
沈殿を吸引し、水で充分に洗浄し、次いで、塩
化メチレン中に取り、乾燥させる。nat.15α−
メシロキシ−3,3−(2′,2′−ジメチル−1′,
3′−プロピレンジオキシ)−18−メチル−5−
もしくは−5(10)−エストレン−17−オンが油状
物として得られる。(c) nat.15α-hydroxy-3,3-(2',2'-dimethyl-1',3'-propylenedioxy)-18-
Methyl-5- or -5(10)-estrene-17
27.1 ml of methylene sulfochloride was added to 37 g of -one in 370 ml of pyridine under ice cooling, and the mixture was stirred at ice bath temperature for 3 hours. Then stirred and introduced into ice water,
The precipitate is aspirated, washed thoroughly with water, then taken up in methylene chloride and dried. nat.15α−
Mesyloxy-3,3-(2',2'-dimethyl-1',
3′-propylenedioxy)-18-methyl-5-
Alternatively, -5(10)-estren-17-one is obtained as an oil.
(d) nat.−15α−メシロキシ−3,3−(2′,2′−
ジメチル−1′,3′−プロピレンジオキシ)−18
−メチル−5−もしくは−5(10)−エストレン−
17−オン35gをジメチルホルムアミド350ml中
で、無水酢酸ナトリウム105gと共に室温で20
時間撹拌する。次いで、氷水中に撹拌導入し、
得られる沈殿を吸引し、洗浄しかつ塩化メチレ
ン中に入れる。蒸発濃縮の後に粗製nat.3,3
−(2′,2′−ジメチル−1′,3′−プロピレンジオ
キシ)−18−メチル−5−もしくは−5(10),15
−エストラジエン−17−オン28.9gが得られ
る。(d) nat.−15α-mesyloxy-3,3-(2′,2′-
dimethyl-1',3'-propylenedioxy)-18
-Methyl-5- or -5(10)-estrene-
35 g of 17-one was dissolved in 350 ml of dimethylformamide with 105 g of anhydrous sodium acetate at room temperature for 20 min.
Stir for an hour. Next, stir and introduce into ice water,
The resulting precipitate is aspirated, washed and taken up in methylene chloride. After evaporative concentration crude nat.3,3
-(2',2'-dimethyl-1',3'-propylenedioxy)-18-methyl-5- or -5(10),15
28.9 g of -estradien-17-one are obtained.
Claims (1)
基を表わし、△は1個の二重結合及び2個の単
結合により隣接炭素原子と結合している炭素原
子を表わし、R1はメチル基を表わす〕のエス
トレン−3,17−ジオン誘導体を製造するた
め、一般式(): 〔式中R1は前記と同じものを表わす〕のステ
ロイドをペニシリウム属の菌培養物を用いて醗
酵させ、生じた一般式(): 〔式中R1は前記のものを表わす〕の15α−ヒド
ロキシステロイドを任意の順序で、2〜6個の
炭素原子を有するアルカンジオール又はo−ジ
フエノールを用いて酸性触媒の存在下にケター
ル化し、かつ塩基の存在でスルホン酸クロリド
を用いてアシル化し、かつ得られた一般式
(): 〔式中△及びR1は前記と同じものを表わし、
X′はプロピレンジオキシ基を表わし、Yはメ
シロキシ基を表わす〕の化合物を塩基で処理す
ることにより一般式()の△15−ステロイド
に変じ、所望の場合には、得られたケタールを
公知方法で加水分解することを特徴とする、エ
ストレン−3,17−ジオン誘導体の製法。[Claims] 1 General formula (): [In the formula, X represents an oxo group or a propylene dioxy group, △ represents a carbon atom bonded to an adjacent carbon atom through one double bond and two single bonds, and R 1 represents a methyl group. To prepare the estrene-3,17-dione derivative of the general formula (): [In the formula, R 1 represents the same thing as above] is fermented using a Penicillium genus bacterial culture, resulting in a general formula (): ketalizing the 15α-hydroxysteroid of the formula in which R 1 is as defined above with an alkanediol or o-diphenol having 2 to 6 carbon atoms in any order in the presence of an acidic catalyst; and acylated with sulfonic acid chloride in the presence of a base, and the obtained general formula (): [In the formula, △ and R 1 represent the same as above,
X′ represents a propylene dioxy group and Y represents a mesyloxy group] is converted into a △ 15 -steroid of the general formula () by treating it with a base, and if desired, the obtained ketal can be converted into a △ 15 -steroid of the general formula () A method for producing an estrene-3,17-dione derivative, which comprises hydrolyzing it by a method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2740784A JPS6054696A (en) | 1984-02-17 | 1984-02-17 | Production of estorene-3, 17-dione derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2740784A JPS6054696A (en) | 1984-02-17 | 1984-02-17 | Production of estorene-3, 17-dione derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6054696A JPS6054696A (en) | 1985-03-29 |
JPH0370720B2 true JPH0370720B2 (en) | 1991-11-08 |
Family
ID=12220221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2740784A Granted JPS6054696A (en) | 1984-02-17 | 1984-02-17 | Production of estorene-3, 17-dione derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6054696A (en) |
-
1984
- 1984-02-17 JP JP2740784A patent/JPS6054696A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6054696A (en) | 1985-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0075189B1 (en) | 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation | |
JPH0121759B2 (en) | ||
EP1562974B1 (en) | Processes for preparing c-7 substituted 5-androstenes | |
US7002028B2 (en) | 5-androsten-3β-ol steroid intermediates and processes for their preparation | |
US4036695A (en) | Process for the preparation of estrene-3,17-dione derivatives | |
JPH0370720B2 (en) | ||
MXPA05004913A (en) | Processes for preparing 7-carboxy substituted steroids. | |
JPS6137280B2 (en) | ||
JPH0665283A (en) | New process for producing 20-keto-21alpha-hydroxysteroid compound and intermediate | |
EP0941361B1 (en) | A method for the preparation of steroid compounds | |
JPH0257559B2 (en) | ||
HU183019B (en) | Process for preparing 5-androsten-17-one derivatives | |
JP2004307390A (en) | Method for producing steroid compound | |
US20040265948A1 (en) | Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters | |
JPH0460480B2 (en) | ||
US20060100185A1 (en) | 5-Androsten-3beta-ol steroid intermediates and processes for their preparation | |
JPS6319157B2 (en) | ||
JPH0576387A (en) | New production of 14alpha-hydroxy-4-androsten-3,6,17-trione | |
JPS637795A (en) | Production of 7alpha-hydroxyandrost-4-ene-3,17-dione | |
EP1679317A2 (en) | 5-Androsten-3 -ol steroid intermediates and processes for fheir preparation | |
JPH0120880B2 (en) | ||
JPS6224077B2 (en) |